1-16044378-C-CACACACACA
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000085.5(CLCNKB):c.-7-108_-7-107insACACACACA variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 0)
Consequence
CLCNKB
NM_000085.5 intron
NM_000085.5 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0860
Publications
2 publications found
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
CLCNKB Gene-Disease associations (from GenCC):
- Bartter disease type 3Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Bartter disease type 4BInheritance: AR Classification: STRONG Submitted by: G2P
- Bartter syndrome type 4Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Gitelman syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000085.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLCNKB | TSL:1 MANE Select | c.-7-108_-7-107insACACACACA | intron | N/A | ENSP00000364831.5 | P51801-1 | |||
| CLCNKB | c.-115_-114insACACACACA | 5_prime_UTR | Exon 1 of 19 | ENSP00000576333.1 | |||||
| CLCNKB | c.-7-108_-7-107insACACACACA | intron | N/A | ENSP00000576322.1 |
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151080Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
151080
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00000662 AC: 1AN: 151080Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 73658 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
151080
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
73658
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41206
American (AMR)
AF:
AC:
0
AN:
15146
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3460
East Asian (EAS)
AF:
AC:
1
AN:
5132
South Asian (SAS)
AF:
AC:
0
AN:
4756
European-Finnish (FIN)
AF:
AC:
0
AN:
10424
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67664
Other (OTH)
AF:
AC:
0
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.